Mary Ann Gray

Mary Ann Gray

DirectoratKeros Therapeutics· In proxies 2023–2025

Mary Ann Gray sits on 4 public boards.

Boards1

  • Keros TherapeuticsDirector · 3 yr on the boardIndependentAudit (Chair), Compensation—Paid as an executive

Board seats come from each company's latest proxy statement.

Experience

  1. Keros TherapeuticsPublic company · 3 yr
    • Director2023 – Present · 3 yrStock in role -74%
  2. BioAtla, Inc.Public company
    • Director? – PresentNo stock prices for these years
  3. Compass Therapeutics Inc.Public company
    • Director? – PresentNo stock prices for these years
  4. Rapt Therapeutics, Inc.Public company
    • Director? – PresentNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?